Similar articles

• A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study.

  Than M, Cullen L, Reid CM, Lim SH, Aldous S, Ardagh MW, Peacock WF, Parsonage WA, Ho HF, Ko HF, Kasliwal RR, Bansal M, Soerianata S, Hu D, Ding R, Hua Q, Seok-Min K, Sritara P, Sae-Lee R, Chiu TF, Tsai KC, Chu FY, Chen WK, Chang WH, Flaws DF, George PM, Richards AM. Than M, et al. Lancet. 2011 Mar 26;377(9771):1077-84. doi: 10.1016/S0140-6736(11)60310-3. Lancet. 2011. PMID: 21435709 Clinical Trial.
• Elevated CK-MB with a normal troponin does not predict 30-day adverse cardiac events in emergency department chest pain observation unit patients.

  Safdar B, Bezek SK, Sinusas AJ, Russell RR, Klein MR, Dziura JD, D'Onofrio G. Safdar B, et al. Crit Pathw Cardiol. 2014 Mar;13(1):14-9. doi: 10.1097/HPC.0000000000000001. Crit Pathw Cardiol. 2014. PMID: 24526146
• [Leading symptoms of chest pain in the emergency room. Using cardiac markers for risk stratification].

  Walter S, Carlsson J, Cuneo A, Tebbe U. Walter S, et al. Dtsch Med Wochenschr. 2001 Jul 6;126(27):771-8. doi: 10.1055/s-2001-15559. Dtsch Med Wochenschr. 2001. PMID: 11486476 German.
• The value of biochemical markers for risk stratification prior to hospital admission in acute chest pain.

  Herlitz J, Svensson L. Herlitz J, et al. Acute Card Care. 2008;10(4):197-204. doi: 10.1080/17482940802409662. Acute Card Care. 2008. PMID: 18781448 Review.
• Use of biomarkers in the emergency department and chest pain unit.

  Jaffe AS. Jaffe AS. Cardiol Clin. 2005 Nov;23(4):453-65, vi. doi: 10.1016/j.ccl.2005.08.013. Cardiol Clin. 2005. PMID: 16278117 Review.